Celator Pharmaceuticals' Series D Round

Celator Pharmaceuticals raised a round of funding on September 16, 2010.

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…

Articles about Celator Pharmaceuticals' Series D Round: